The effect is usually temporary as your body adapts over weeks
While the formulation patent for oral Wegovy remains valid in major markets such as the United States, the European Union, and Japan until 2039, the company explains that it can circumvent this through its proprietary formulation technology S-PASS. Ildong Pharmaceutical has also set a plan to achieve both technology licensing and entry into Phase 2 clinical trials this year for ID110521156, an oral GLP-1based new drug candidate
Pre-existing migraine history, medication sensitivity, dosing schedule, and individual metabolic responses all influence headache likelihood
When IgG4-RD involves the central nervous system or surrounding areas, it may cause: Persistent headaches Eye pain or swelling Facial numbness Neurological symptoms like vision or hearing changes Chronic sinus problems These symptoms may resemble migraines, tension-type headaches, or sinus infections, which is why understanding the link between IgG4-RD and chronic headaches is essential
However, further investigations in larger populations are required to confirm the contribution of the GPX4 gene to the risk of CS, and to assess the relationship between the GPX4 genotype and the enzyme expression/activity
Comparing Semaglutide and Metformin For Weight Loss & Diabetes Side Effects Cost Differences FAQs What Is Semaglutide
